Company / Free Cash Flow
PAVmed Inc. Free Cash Flow History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$33.6M
FY2025
5-year range
-$72.5M / -$22.0M
FY2021-FY2025
Trend
+35.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -$73M to -$34M over the past 2 years.
Based on SEC 10-K filings.
-$34M in FY2025.
Improved from -$73M to -$34M over the past 2 years.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, free cash flow increased 35.7% year-over-year.
- Peak free cash flow was recorded in FY2021.
- Lowest free cash flow in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -0.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$33.6M | +35.7% |
| FY2024 | -$52.3M | +27.9% |
| FY2023 | -$72.5M | -72.4% |
| FY2022 | -$42.1M | -91.5% |
| FY2021 | -$22.0M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026